FDA Adds Delsam Pharma’s Artificial Eye Ointment to List of Recalled Eye Drops Recall
Recalled Artificial Eye Ointment carries the same risk of bacterial contamination that resulted in recent Artificial Tears eye drops recall, FDA warns.
Recalled Artificial Eye Ointment carries the same risk of bacterial contamination that resulted in recent Artificial Tears eye drops recall, FDA warns.
Lawsuit alleges contaminated eye drops caused vision loss and surgery, joining a growing number of Artificial Tears lawsuits filed since a recall was announced due to bacterial contamination.
Lawsuit alleges contaminated eye drops caused a Pseudomonas aeruginosa infection and antibiotics did little to help fight off the treatment-resistant bacterial contamination
Florida woman had to undergo eye surgery after normal treatments failed to work agains a Pseudomonas Aeruginosa eye drops infection
Dozens of infections have been linked to the contaminated eye drops, including at least one death, and a growing number of Artificial Tears lawsuits and class action claims are being pursued
Class action lawsuit over recalled eye drops alleges Delsam Pharma and EzriCare Artificial Tears were not adequately treated to prevent bacterial contamination.
The Artificial Tears eye drops recall follows at least 50 reports of severe infections, resulting in vision loss, hospitalizations and at least one death
CDC has received at least 50 reports of severe eye infections from EzriCare Artificial Tears, including vision loss and at least one death.